Chinese Province Implements Pilot Quality System To Strengthen Drug Safety
This article was originally published in PharmAsia News
Executive Summary
SHANGHAI - In the latest effort to strengthen drug safety measures in China, Guangdong province has taken a page out of the international quality systems playbook, launching a pilot system July 20 that assigns responsibility for drug manufacturing quality to a designated company official
You may also be interested in...
SFDA Issues Revised GMP Draft Guideline Following Industry Comments; Expects Compliance To Come In Stages
SHANGHAI - Following industry comments, China's State FDA released another draft GMP guideline for which it seeks additional public comments. The revised draft offers clarity on a few key points but still leaves huge gaps that will need to be filled slowly over time
SFDA Issues Revised GMP Draft Guideline Following Industry Comments; Expects Compliance To Come In Stages
SHANGHAI - Following industry comments, China's State FDA released another draft GMP guideline for which it seeks additional public comments. The revised draft offers clarity on a few key points but still leaves huge gaps that will need to be filled slowly over time
China's FDA Issues Revised GMP Draft Guideline Following Industry Comments; Expects Compliance To Come In Stages
"It will be interesting to see how much of a grace period is given for manufacturers to meet standards, or whether certain manufacturers will be 'grandfathered' under old rules," industry consultant says.